Booster Therapeutics: Funding, Investors & Team (Sep 2026)
Booster Therapeutics is pioneering a new class of medicines that activate proteasomes (the cell’s natural quality control machinery) to treat a range of complex indications. The company is developing a multi-disease pipeline, with an initial focus on neurodegenerative diseases associated with impaired proteasome function.
Booster Therapeutics has raised $15.0M across 1 funding round on record, the most recent a Seed of $15.0M announced in Oct 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Booster Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Booster Therapeutics Funding Rounds
Booster Therapeutics Founders and Leadership Team
Contact details for the Booster Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Booster Therapeutics Funding Compared to Other Biotechnology Startups
Booster Therapeutics' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Booster Therapeutics in Biotechnology and Berlin
Companies Similar to Booster Therapeutics
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Booster Therapeutics Funding FAQs
What does Booster Therapeutics do?
Booster Therapeutics is pioneering a new class of medicines that activate proteasomes (the cell’s natural quality control machinery) to treat a range of complex indications. The company is developing a multi-disease pipeline, with an initial focus on neurodegenerative diseases associated with impaired proteasome function.
How much funding has Booster Therapeutics raised?
Booster Therapeutics has raised $15.0M across 1 round on record. The most recent is a Seed of $15.0M announced in Oct 2024.
When did Booster Therapeutics last raise funding?
Booster Therapeutics' most recent funding round on record is a Seed of $15.0M, announced in Oct 2024.
Who founded Booster Therapeutics?
FundedIQ lists Diogo R Feleciano (Founder) at Booster Therapeutics.
Where is Booster Therapeutics headquartered?
Booster Therapeutics is based in Berlin, Germany.
How many employees does Booster Therapeutics have?
Booster Therapeutics is in the 1-10 employee band.
How does Booster Therapeutics' funding compare to other Biotechnology startups?
Booster Therapeutics' latest round of $15.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Booster Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Booster Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.